SCHEMBL168253

SCHEMBL168253

CCCCCCc1c(C(=O)O)c(C(=O)O)c2cccc(CC)c2c1CC

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BID P55957 6/20 0.53
MCL1 Q07820 6/20 0.53
BCL2L1 Q07817 5/20 0.53
BAK1 Q16611 5/20 0.53
KAT8 Q9H7Z6 3/20 0.53
PPARA Q07869 3/20 0.53
PPARG P37231 2/20 0.53
EP300 Q09472 2/20 0.53
KAT5 Q92993 2/20 0.53
SAE1 Q9UBE0 2/20 0.53
KAT2A Q92830 1/20 0.53
KAT2B Q92831 1/20 0.53
F7 P08709 3/20 0.47
F3 P13726 3/20 0.47
MMP2 P08253 2/20 0.47
KDM4E B2RXH2 1/20 0.47
MAPT P10636 1/20 0.47
ALOX15 P16050 1/20 0.47
ECE1 P42892 1/20 0.47
SGMS1 Q86VZ5 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29733639 1.00 BID (0.53) BIDMCL1BCL2L1BAK1KAT8
SCHEMBL9329841 0.85 BID (0.50) BIDMCL1BCL2L1BAK1KAT8
SCHEMBL25261007 0.80 BID (0.50) BIDMCL1BCL2L1BAK1KAT8
SCHEMBL1176170 0.80 BID (0.50) BIDMCL1BCL2L1BAK1KAT8
SCHEMBL7594362 0.79 BID (0.48) BIDMCL1BCL2L1BAK1KAT8
SCHEMBL34463710 0.78 BID (0.49) BIDMCL1BCL2L1BAK1KAT8
SCHEMBL29138979 0.78 BID (0.54) BIDMCL1BCL2L1BAK1KAT8
SCHEMBL6383337 0.78 KAT8 (0.46) BIDMCL1BCL2L1BAK1KAT8
SCHEMBL168254 0.78 BID (0.48) BIDMCL1BCL2L1BAK1KAT8
SCHEMBL7944628 0.76 BID (0.46) BIDMCL1BCL2L1BAK1KAT8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 430 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2501777-B1 BROAD SPECTRUM UVA STABLE, NON-TOXIC, ZINC OXIDE BASED COMPLEX GRUNE GUERRY L (US) 2022-10-26 EP claimed
EP-2939710-B1 Active Mixtures SYMRISE AG (DE) 2020-06-17 EP claimed
EP-2819643-B1 SUNSCREEN COMPOSITION COMPRISING UV COMPOSITE PROCTER & GAMBLE (US) 2017-10-18 EP claimed
EP-1618868-B1 Process for photostabilising a dibenzoylmethane derivative with an arylalkyl benzoate derivative and a bis-resorcinyl triazine compound and sunscreening cosmetic compositions ORÉAL L (FR) 2015-11-04 EP claimed
EP-1453478-B1 COSMETIC AND DERMATOLOGICAL LIGHT PROTECTIVE FORMULATIONS WITH A CONTENT OF PARTICULAR UV FILTER SUBSTANCES AND ALKYLNAPHTHALATES BEIERSDORF AG (DE) 2011-10-12 EP claimed
EP-1129696-B1 Stabilization of oxidation- and/or UV- sensitive active agents BEIERSDORF AG (DE) 2006-11-15 EP claimed
EP-1237532-B1 ULTRAVIOLET RADIATION ABSORBING WAXES USEFUL IN COSMETIC COMPOSITIONS CPH INNOVATIONS CORP (US) 2006-03-08 EP claimed
EP-1458332-A1 CLEANING PRODUCTS BASED ON MICROEMULSIONS THAT CONTAIN OIL Beiersdorf AG (DE) 2004-09-22 EP claimed
WO-2004024110-A1 COSMETIC PREPARATION BASED ON OIL-CONTAINING MICROEMULSIONS BEIERSDORF AG (DE) 2004-03-25 WO claimed
WO-2003051319-A1 CLEANING PRODUCTS BASED ON MICROEMULSIONS THAT CONTAIN OIL BEIERSDORF AG (DE) 2003-06-26 WO claimed
EP-4025675-B1 A PERFUME OIL MIXTURE SYMRISE AG (DE) 2026-03-18 EP disclosed
US-20260041095-A1 A PRESERVATION METHOD ANALYTICON DISCOVERY ZWEIGNIEDERLASSUNG DER BRAIN BIOTECH AG (DE) 2026-02-12 US disclosed
US-12545851-B2 Fragrances with note of lily of the valley SYMRISE AG (DE) 2026-02-10 US disclosed
US-20260034044-A1 A PRESERVATIVE COMPOSITION ANALYTICON DISCOVERY ZWEIGNIEDERLASSUNG DER BRAIN BIOTECH AG (DE) 2026-02-05 US disclosed
US-12534685-B2 Fragrance composition SYMRISE AG (DE) 2026-01-27 US disclosed
WO-2002038537-A1 NOVEL INDANYLIDENE COMPOUNDS HAARMANN & REIMER GMBH (DE) 2002-05-16 WO disclosed
WO-2001089452-A2 STABLE EMULSIONS FOR COSMETIC PRODUCTS COLGATE-PALMOLIVE COMPANY (US) 2001-11-29 WO disclosed
EP-1129696-A2 Stabilisation of oxidation- and/or UV-sensitive compounds Beiersdorf AG (DE) 2001-09-05 EP disclosed
EP-1127569-A2 Cosmetic and dermatological light protective formulations containing asymmetrically substituted triazine derivatives and alkylnaphthalates Beiersdorf AG (DE) 2001-08-29 EP disclosed
EP-1127568-A2 Cosmetic and dermatological light protective formulations containing benzotriazole derivatives and alkylnaphthalates Beiersdorf AG (DE) 2001-08-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260041095-A1 A PRESERVATION METHOD LSS, ASAH2, CUTA BID 4411/4885MCL1 1455/4885BCL2L1 412/4885
US-12534685-B2 Fragrance composition NCLN, HCN2, TRPA1 BID 3485/4885MCL1 772/4885BCL2L1 1464/4885
US-12545851-B2 Fragrances with note of lily of the valley TRPA1, CDY1; CDY1B, TMEM109 BID 2827/4885MCL1 1266/4885BCL2L1 423/4885
US-20260034044-A1 A PRESERVATIVE COMPOSITION ERG28, FOXO3, DEGS1 BID 3708/4885MCL1 714/4885BCL2L1 308/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.